VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Icanic Brands Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or the “Company”), a multi-state brand operator of premium cannabis brands in California, is pleased to announce that it has signed a non-binding Letter of Interest (“LOI”) to acquire DNA Organics, Inc. (“Lifted”), a premium California cultivator and manufacturer (the “Proposed Acquisition”).
About Lifted Lifted is a vertically integrated California cannabis company specializing in cultivation and solventless manufacturing using sustainable, organic practices with a focus on achieving economies of scale through adoption and adaptation of existing commercial agriculture and manufacturing solutions. Lifted was founded in 2012 after the passage of California Proposition 215 and has over 10 years of successful cannabis cultivation and manufacturing operations making Lifted uniquely positioned to capitalize on California’s legalization of recreational cannabis. Founded in the mountains of Santa Cruz, Lifted is currently headquartered in Watsonville, unincorporated Santa Cruz County, a primary hub of agriculture in California and the United States providing world class access to scaled commercial cultivation & processing resources. Lifted currently has 20.25 acres of licensed outdoor canopy. Lifted is a market leader in fresh frozen flower production as well as live solventless extracts. Lifted currently has 100% of its cultivation under contract with three of the largest companies in California including Buddies, Jetty and LEEF brands. Lifted has been a trusted supply chain partner for LEEF in the past and has proven to be one of the best cultivation groups in the state, cultivating high yielding, pesticide free cannabis year after year.
Currently producing 240k lbs fresh frozen per year
Under contract with Buddies, Jetty Extracts, and LEEF
Specialty in fresh frozen material
Proprietary list of high yielding genetics
Utilize Lifted Organics’ raw inputs to power Icanic’s existing extraction lines
Integrate raw inputs from Lifted Organics into Icanic’s higher margin branded portfolio
Strengthen business-to-business relationships through the ability to offer Icanic’s partners additional supply chain
Consolidate operating expenses onto Icanic’s existing team to improve efficiencies
“We are very excited to welcome the Lifted Organics team to our family. With the addition of the 20 acres to our supply chain, it will allow Icanic to expedite our dedication to providing industry best gross margins on our internal brand portfolio while being able to offer a more robust solution to our brand manufacturing partners who are some of the largest companies in the state,” said Brandon Kou, CEO of Icanic Brands. “This accretive acquisition should significantly reduce COGS with the addition of an industry leader within the cultivation supply chain and provide a platform to continue to grow our robust and dynamic genetics portfolio. Lifted Organics is the latest example of how we are able to grow through our merger & acquisition process and provide significant value to our shareholders.”
“We are excited at the prospect of joining the Icanic team. Over the past 18 months we’ve seen them hard at work, aligning the right industry segments in efforts to streamline high quality production that will positively impact consumer experience across the board. With our combined efforts we think it will be difficult to find a competitor that can match our quality of product and process efficiencies to suit the best brands out there,” said Dave Doriot, CEO of Lifted Organics.
Under the terms of the LOI, the purchase price (the “Purchase Price”) will be comprised of (i) the Closing Purchase Price (as defined below), and (ii) the Earn-Out Payments (as defined below).
The initial payment forming part of the Purchase Price (the “Closing Purchase Price”) will be 1.0x multiple of revenue for the period beginning September 30th, 2022 till September 30th, 2023, less the estimated revenue value of the current inventory on hand calculated at the time of close and less any estimated revenue value of produced between the time of close until September 30th, 2022. The Closing Purchase Price will be satisfied in full through the issuance of common shares of the Company (the “Icanic Shares”).
The earn-out payment forming part of the Purchase Price (the “Earn-Out Payments”) will be paid as follows:
(a) performance milestone of 10% of the difference in the Closing Purchase Price and a 1.0x multiple of the subsequent 12 months of revenue following the closing date of the Proposed Acquisition; and
(b) milestone based consideration derived from achieving revenue targets.
Each of the foregoing Earn-Out Payments will be satisfied in full through the issuance of Icanic Shares.
In the event the Purchase Price does not exceed $5,000,000 USD, Ionic agrees to pay the difference such that the total consideration shall equal to $5,00,000 USD. Such payment will be satisfied in full through the issuance of Icanic Shares.
The Company further announces that it will issue an aggregate of 3,764,858 common shares pursuant to the terms of its previously announced acquisition of THC Engineering, LLC. On May 7, 2021, the Company announced that it had completed the acquisition (the “Acquisition”) of THC Engineering, LLC (“THC Engineering”) and THC Engineering Holdings, LLC (“THC Holdings”, and collectively with THC Engineering, “THC”) and pursuant to the terms of a share exchange agreement dated April 7, 2021 (the “Share Exchange Agreement”) among the Company, THC and the unitholders of THC (the “THC Unitholders”).
Pursuant to the terms of the Share Exchange Agreement, the Company will issue 1,755,078 common shares (the “Consideration Shares”) which equates to 50% of the shares paid for consideration; and 2,009,780 common shares (the “Milestone Shares”) for the portion currently owed for meeting one of the milestones as defined in the Share Exchange Agreement. The Consideration Shares and Milestone Shares have been issued at a deemed price of CAD$0.239 per share and are subject to a four-month hold period and resale conditions as required by applicable securities laws and the policies of the Canadian Securities Exchange. The price per share was determined by calculating the volume-weighted average trading price of the Company’s common shares for the ten (10) days ending on the day prior to the achievement of the certain milestones pursuant to the Share Exchange Agreement.
Please see the Company’s news releases dated May 7, 2021; April 15, 2021; and December 9, 2021, for more information.
About Icanic Brands Company Inc. Icanic Brands Company Inc. is a cannabis branded products manufacturer based in California, the largest cannabis markets in the world. The company’s mission is to build a great cannabis company with great people and great results.
For more information, please visit the company’s website at: www.icaninc.com.
Leef Holdings, Inc. (“Leef”), a wholly owned subsidiary of Icanic Brands Company Inc. (CSE: ICAN, OTCQB: ICNAF) is one of the largest cannabis extraction companies in the state of California and is a leading provider of bulk concentrates to many of the largest brands in the state. It is led by an expert group of legacy operators with decades of experience in organic soil-based farming and sophisticated extraction practices. LEEF’s manufacturing capabilities include a 12,000 square foot extraction and manufacturing facility with significant throughput and concentrate extraction capability.
For more information about Leef, visit their website at www.leefca.com
Ganja Gold, a wholly owned subsidiary of Icanic Brands Company Inc. (CSE: ICAN, OTCQB: ICNAF), is the premier brand of infused pre-rolls in the state. Ganja Gold focuses on using only the best available flower and concentrates with state of the art proprietary technology to create connoisseur level pre-rolls unseen in the marketplace. With our flagship Tarantula™, Ganja Gold continues to set the bar in quality and experience.
For more information about Ganja Gold, visit their website at www.ganjagold.com
About de Krown Enterprises LLC
de Krown Enterprises LLC (“de Krown”), a wholly owned subsidiary of Icanic Brands Company Inc. (CSE: ICAN, OTCQB: ICNAF), is a California-based manufacturing partner and brand owner. de Krown has the expertise to provide all types of cannabis services including pre-roll manufacturing, cartridge filling, product packaging, extraction, terpene extraction and topicals/edibles.
For more information about de Krown, visit their website at www.dekrown.com
For further information about Icanic Brands, please contact the Company at: Email: ir@icaninc.com
The CSE does not accept responsibility for the adequacy or accuracy of this release.
This news release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable Canadian and United States securities laws (collectively, “forward-looking information”). Forward-looking information are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking information in this news release includes, without limitation, statements relating to the completion of the Proposed Acquisition, the entering into of a definitive agreement based on the LOI, the growth of the California consumer segment of the California cannabis market, the total annual revenue of Lifted, the anticipated consolidated financial results associated with the completion of the Proposed Acquisition, the receipt of all requisite approvals to complete the Proposed Acquisition, the Company’s goals following closing of the Proposed Acquisition and the Company’s business and strategic plans. Forward-looking information is based on assumptions that may prove to be incorrect, including but not limited to the ability of the Company to execute its business plan, the continued growth of the medical and/or recreational cannabis markets in the countries in which the Company operates or intends to operate and Lifted maintaining its existing cannabis licenses. The Company considers these assumptions to be reasonable in the circumstances. However, forward-looking information is subject to business and economic risks and uncertainties and other factors that could cause actual results of operations to differ materially from those expressed or implied in the forward-looking information. Such risks include, without limitation: the failure to negotiate and execute a definitive agreement with Lifted satisfactory to the respective parties, the failure to obtain all necessary approvals related to the LOI, the ability of the Company to complete the Proposed Acquisition in a timely manner or at all; the receipt of requisite approvals to complete the Proposed Acquisition; the ability of the Company to integrate the Lifted business into its existing operations and to realize the expected benefits and synergies of the acquisition; unexpected disruptions to the operations and businesses of the Company and/or Lifted as a result of the COVID-19 global pandemic or other disease outbreaks including a resurgence in the cases of COVID-19; engaging in activities considered illegal under United States federal law; the ability of the Company to comply with applicable government regulations in a highly regulated industry; unexpected changes in governmental policies and regulations affecting the production, distribution, manufacture or use of cannabis in the United States, or any other foreign jurisdictions in which the Company intends to operate; unexpected changes in governmental policies and regulations affecting the production, distribution, manufacture or use of adult-use recreational cannabis in the United States or Canada; any change in accounting practices or treatment affecting the consolidation of financial results; any unexpected failure of Lifted to renew its licenses and permits; any unexpected failure of Lifted to maintain any of its commercial facilities; the Company’s reliance on management; inconsistent public opinion and perception regarding the use of cannabis; perceived effects of medical cannabis products; adverse market conditions; the inherent uncertainty of production and cost estimates and the potential for unexpected costs and expenses; costs of inputs; crop failures; litigation; currency fluctuations; competition; availability of capital and financing on acceptable terms; industry consolidation; loss of key management and/or employees; and other risks detailed herein and from time to time in the filings made by the Company with securities regulators. For more information on the Company and the risks and challenges of their businesses, investors should review their annual filings that are available at www.sedar.com.
Markets have well and truly changed direction from last year’s bullish trends. The downward shift has brought us a major selloff, and declines of 27% and more in the tech-heavy NASDAQ index. For investors, it’s a situation that requires a close watch on the markets, and clear eye for the opportunities that will pop out as conditions change. It’s also a situation in which investors can use expert advice. Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program, tells investors that when the
Entering the final day of trading this week, the stock of Chinese electric vehicle maker Nio (NYSE: NIO) had been down more than 12% just this week, and more than 25% over the past month. After rising more than 9% Friday morning, Nio American depositary shares (ADSs) were still up 7.1% as of 10:50 a.m. ET. There are fears the U.S.-listed ADSs could be delisted as the company joined a growing list of Chinese names that will be required to provide proof of meeting U.S. accounting and audit standards for three straight years.
Shares of Boeing (NYSE: BA) joined the rally on Friday morning, trading up more than 6% at one point, only to give up most of those gains as they day went on. Investors got a reminder of the challenges that face Boeing's commercial division, taking the wind out of the shares. It's been a tough run for Boeing, with shares down by more than 60% since the start of 2020.
Nvidia (NASDAQ: NVDA) shareholders were in for a pleasant surprise Friday as the semiconductor maker made significant gains. As of 1:05 p.m. ET, Nvidia's share price had surged by 9.8% as investors became more bullish about the market in general. The tech-heavy Nasdaq Composite was up by nearly 4% at that point in the session.
In this article, we will discuss the 12 best energy stocks for 2022. If you want to skip our detailed analysis of the energy sector which highlights key trends and major players, you can go directly to 5 Best Energy Stocks for 2022. The energy sector has been the biggest contributor to skyrocketing inflation in […]
High-growth profitless stocks bounced big on Friday. A mere short-covering bounce, or the start of more upside?
It can be unsettling for shareholders, but that's the volatility investors need to brace for right now. A couple of stocks that recently fell to all-time lows after reporting earnings are GoodRx (NASDAQ: GDRX) and Palantir Technologies (NYSE: PLTR). Shares of GoodRx got hammered, falling more than 25% on Tuesday after the company released its latest earnings numbers -- and that's despite encouraging results.
Canadian cannabis company Aurora Cannabis (NASDAQ: ACB) reported its fiscal third-quarter 2022 earnings last night, and in so doing, sparked a rally across the cannabis sector today. As of 1 p.m. ET, shares of Aurora Cannabis itself are already up 13%, and peer producers Canopy Growth (NASDAQ: CGC) and Sundial Growers (NASDAQ: SNDL) are benefiting as well -- up 8.5% and 5.9%, respectively. Heading into Q3, analysts had forecast that Aurora Cannabis would lose $0.19 per share (0.25 Canadian dollars, and furthermore, this was a pro forma prediction) on sales of $41.5 million -- about CA$53.7 million.
Feel poorer after the S&P 500's sell-off? Just know it could be worse. Much worse. Investors who piled in some $40 billion firms found out.
(Reuters) -Elon Musk tweeted on Friday that his $44-billion cash deal for Twitter Inc was “temporarily on hold” while he waits for the social media company to provide data on the proportion of its fake accounts. Twitter shares initially fell more than 20% in premarket trading, but after Musk, the chief executive of electric car market Tesla Inc, sent a second tweet saying he remained committed to the deal, they regained some ground. The shares were down 9.6% to $40.71 in trading on Friday, a steep discount to the $54.20 per share acquisition price.
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Shares of Duolingo (NASDAQ: DUOL) soared on Friday after the mobile learning platform delivered strong first-quarter growth metrics and boosted its full-year financial forecast. Duolingo's revenue rose 47% year over year to $81.2 million, besting Wall Street's expectations for sales of $77.6 million. "All elements of our business performed well this quarter and we saw accelerating user growth, record quarterly bookings, and strong margins," CEO Luis von Ahn said in a press release.
The stock market presents a somewhat confusing picture for now. The main indexes are all steeply down for the year so far – with losses of 16% on the S&P 500 and 25% on the NASDAQ. Drops of this magnitude come with a caveat, however: it’s inevitable that some fundamentally sound stocks are seeing drops in share price just due to the overall market’s downward trend. Indeed, Wall Street’s analysts are seeing plenty, in their words, attractive entry points -- beaten-down stocks that are primed for
These blue chip stocks can generate steady passive income in even the most challenging environments.
Several companies have announced stock splits this year. While investors were initially enthusiastic, that sentiment has faded as macroeconomic headwinds have pummeled the market. The growth-heavy Nasdaq Composite is now down 28% from its high, and many popular stocks have fallen even further.
Investors are rethinking valuations even as these EV companies continue to make progress growing their businesses.
Our call of the day from Thomas Kee Jr. is pounding the table over the importance of volatility, but says investors need to not just fear the lows, but embrace the highs.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of High Tide Inc...
If we let history guide us, the best thing to do with cash in times of market turbulence like we're seeing is to buy dividend stocks. Numerous studies also underscore the fact that dividend stocks outperform stocks that don't pay a dividend by a wide margin. J.P. Morgan Asset Management found that stocks that initiated and then raised their payouts over a 40-year period between 1972 and 2012 returned an average of 9.5% annually, versus just 1.6% for nonpayers.
Biotech is one of the fastest growing areas in healthcare, and one of the more exciting sectors in the stock market. Here's why three Fool.com contributors are bullish on 10x Genomics (NASDAQ: TXG), Axsome Therapeutics (NASDAQ: AXSM), and Doximity (NYSE: DOCS). 10x Genomics sells the machines and associated consumables that allow scientists to look in and around a single cell, referred to as spatial biology.